Dna Canada Inc. : Notice Of Special Meeting Of Shareholders To Be Held On November 27, 2017
By: DNA Canada Inc
Following the absence of further action by the board of directors of the Corporation to hold said special meeting in the twenty-one (21) days following receipt of said Requisition, and in accordance with Section 209 of the Business Corporation Act (Quebec) and with Section 19.06 of the Corporation's by-laws, the Shareholders are calling the Meeting to be held on November 27, 2017 at 10:00 am Eastern Time, at the offices of Dunton Rainville LLP located at 800 Square Victoria, 43rd Floor, Montreal, Quebec H4Z 1H1 for the following purposes:
1.To revoke the current mandate of Mr. Yves Gagnon to act as director and officer of the Corporation and to elect a successor to hold office as director of the Corporation until his resignation, his revocation or until a successor is duly appointed or elected to act as director of the Corporation at the next annual general meeting of the shareholders of the Corporation;
2.To elect Mr. Peter Comito as Chairman of the Board, Kallitsa Chatzis as Director of the Corporation and Jeffrey Bercovitch as director of the Corporation to hold office until the next annual general meeting of the Corporation, or until such time as their successors are duly elected or appointed in accordance with the Corporation's constituting documents;
3.To nominate the following individuals as new officers of the Corporation to hold office until such time as their successors are duly elected or appointed in accordance with the Corporation's constituting documents, namely Peter Comito as President and Chief Executive Officer, Kallitsa Chatzis as Vice-President Operations and business development and Jeffrey Bercovitch as Chief Financial Officer;
4.To consider, and if deemed advisable, to pass, with or without variation, an ordinary resolution adopting a By-laws of the Corporation, which by-law by its terms repeals all previous by-laws governing the Corporation, and the articles of the Corporation in order to comply with the requirements of the applicable securities laws and regulations;
5.To transact such other business as may properly be brought before the Meeting and at any adjournment thereof.
The proxy circular for proxy solicitations which can be downloaded at http://www.dnacanadaproxy.com (also available via email at daniel.mastantuono@
The Shareholders have fixed the close of business on the second to last business day prior to the date of the Meeting, or any adjournment or postponement thereof, as the record date for determination of shareholders entitled to notice of and the right to vote at the Meeting, either in person or by proxy, in accordance with and subject to the provisions of applicable laws.
All shareholders wishing to attend the Meeting shall register with Mr. Daniel Mastantuono at least forty-eight (48) hours prior to the date of the Meeting via email at daniel.mastantuono@
Montreal, November 6, 2017
NOTE: Shareholders eligible to vote but unable to attend personally are requested to complete, sign and forthwith return the form of proxy.